InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
4
T+90 hit rate
59%
T+90 mean return
+1.1%
Across 22 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Landry Robert E, Chief Financial Officer. Officer active across 2 companies, notably Regeneron Pharmaceuticals, INC.. Aggregated, 35 reports have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €1.1m. History available since 6 August 2021. The latest transaction was filed on 27 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations35 total
2,851 shares0Common StockSEC:0001061983-26-000056:0
7,333 shares0Common StockSEC:0001127602-25-014356:0
400 shares@ US$378.980.7% of flowCommon StockSEC:0001968202-24-000053:0
400 shares@ US$378.980.7% of flowCommon StockSEC:0001968202-24-000045:0
1,100 shares@ US$378.981.9% of flowCommon StockSEC:0001968202-24-000040:0
500 shares@ US$378.980.9% of flowCommon StockSEC:0001968202-24-000036:0
800 shares@ US$378.981.4% of flowCommon StockSEC:0001968202-24-000034:0
500 shares@ US$378.980.8% of flowCommon StockSEC:0001968202-24-000031:0
650 shares@ US$378.981.1% of flowCommon StockSEC:0001883850-24-000005:0
750 shares@ US$378.981.3% of flowCommon StockSEC:0001883850-23-000108:0
6,381 shares@ US$856.7124.9% of flowCommon StockSEC:0001883850-23-000100:0
1,013 shares@ US$843.793.9% of flowCommon StockSEC:0001968202-23-000051:0
223 shares@ US$844.000.8% of flowCommon StockSEC:0001968202-23-000030:0
800 shares@ US$381.921.4% of flowCommon StockSEC:0001968202-23-000004:0
739 shares@ US$764.502.5% of flowCommon StockSEC:0001883850-23-000035:0
3,853 shares0Common StockSEC:0001883850-22-000132:0
3,000 shares@ US$381.925.3% of flowCommon StockSEC:0001883850-22-000107:0
2,500 shares@ US$381.924.5% of flowCommon StockSEC:0001883850-22-000102:0
2,000 shares@ US$381.923.8% of flowCommon StockSEC:0001883850-22-000086:0
1,500 shares@ US$381.922.9% of flowCommon StockSEC:0001883850-22-000082:0
1,500 shares@ US$399.660.0008% mcap6.5% of flowCommon StockSEC:0001883850-22-000040:0
1,500 shares@ US$399.660.0007% mcap6.4% of flowCommon StockSEC:0001883850-22-000028:0
1,250 shares@ US$555.670.0009% mcap7.5% of flowCommon StockSEC:0001883850-22-000022:0
300 shares@ US$693.000.0003% mcap2.2% of flowCommon StockSEC:0001708138-22-000028:0
300 shares@ US$677.000.0003% mcap2.2% of flowCommon StockSEC:0001708138-22-000022:0
25 of 35 declarations
About Landry Robert E
Robert E Landry is an executive at REGENERON PHARMACEUTICALS, INC.
